Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recommendations for the registration of agents used in the prevention and treatment of glucocorticoid-induced osteoporosis.
Compston JE, Audran M, Avouac B, Bouvenot G, Devogelaer J, Eastell R, Fabris F, Gennari C, Jones EA, Kaufman JM, Lemmel E, Mazzuoli G, Reid DM, Ringe JD, Vanhaelst L, Ziegler R, Reginster JY. Compston JE, et al. Among authors: ringe jd. Calcif Tissue Int. 1996 Nov;59(5):323-7. doi: 10.1007/s002239900134. Calcif Tissue Int. 1996. PMID: 8849396 No abstract available.
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science.
Compston J, Reid DM, Boisdron J, Brandi ML, Burlet N, Cahall D, Delmas PD, Dere W, Devogelaer JP, Fitzpatrick LA, Flamion B, Goel N, Korte S, Laslop A, Mitlak B, Ormarsdottir S, Ringe J, Rizzoli R, Tsouderos Y, Van Staa T, Reginster JY; Group for the Respect of Ethics and Excellence in Science. Compston J, et al. Osteoporos Int. 2008 Sep;19(9):1247-50. doi: 10.1007/s00198-008-0670-7. Epub 2008 Jul 5. Osteoporos Int. 2008. PMID: 18604578 No abstract available.
Treatment of osteoporosis in men.
Kaufman JM, Reginster JY, Boonen S, Brandi ML, Cooper C, Dere W, Devogelaer JP, Diez-Perez A, Kanis JA, McCloskey E, Mitlak B, Orwoll E, Ringe JD, Weryha G, Rizzoli R. Kaufman JM, et al. Among authors: ringe jd. Bone. 2013 Mar;53(1):134-44. doi: 10.1016/j.bone.2012.11.018. Epub 2012 Nov 28. Bone. 2013. PMID: 23201268 Free PMC article. Review.
A reappraisal of generic bisphosphonates in osteoporosis.
Kanis JA, Reginster JY, Kaufman JM, Ringe JD, Adachi JD, Hiligsmann M, Rizzoli R, Cooper C. Kanis JA, et al. Among authors: ringe jd. Osteoporos Int. 2012 Jan;23(1):213-21. doi: 10.1007/s00198-011-1796-6. Epub 2011 Sep 28. Osteoporos Int. 2012. PMID: 21953472 Free PMC article. Review.
Optimizing the treatment of Paget's disease of bone.
Reginster JY, Gennari C, Hosking DJ, Ringe JD, Meunier PJ. Reginster JY, et al. Among authors: ringe jd. Rev Rhum Engl Ed. 1997 Apr;64(4):207-9. Rev Rhum Engl Ed. 1997. PMID: 9178391 Review. No abstract available.
Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men.
Kaufman JM, Audran M, Bianchi G, Braga V, Diaz-Curiel M, Francis RM, Goemaere S, Josse R, Palacios S, Ringe JD, Felsenberg D, Boonen S. Kaufman JM, et al. Among authors: ringe jd. J Clin Endocrinol Metab. 2013 Feb;98(2):592-601. doi: 10.1210/jc.2012-3048. Epub 2013 Jan 22. J Clin Endocrinol Metab. 2013. PMID: 23341486 Free article. Clinical Trial.
Points to consider for the development of new indications for hormone replacement therapies and estrogen-like molecules. Department of Urogynaecology, King's College Hospital, London.
Stevenson JC, Gaspard U, Avouac B, Bricaire C, Cardozo L, Collins P, Devogelaer JP, Dören M, Gennari C, Kaufman JM, Kuttenn F, Ringe JD, Scarafiotti C, Vanhaelst L, Zichella L, Ziegler R, Reginster JY. Stevenson JC, et al. Among authors: ringe jd. Climacteric. 1998 Mar;1(1):12-7. doi: 10.3109/13697139809080676. Climacteric. 1998. PMID: 11913406 Review. No abstract available.
197 results